A great opportunity for companies in the life sciences industry.
Read More
Prevtec Microbia launches its third vaccine thanks to the support of its shareholders.
Read More
MOVANTIK is commercialized in Canada.
Read More
A BIOQuébec partner has issued its Opening the Door II labour market report.
Read More
The continuing development of Shigamab™ has been guaranteed. This transaction allows BELLUS Health to maintain financing for its activities until the end of 2018.
Read More
A 25% discount on the PetriDish™ job postings board is available to BIOQuébec members!
Read More
A pioneer in the fight against HIV/AIDS has passed away.
Read More
The following recommendations were submitted to the Minister of Finance and to the Minister of the Economy, Science, and Innovation. Their objective is to foster the growth of innovative businesses, facilitate their integration, support innovation, and recognize the contributions of the life sciences industry.
Read More
As part of the pre-budget consultations, BIOQuébec submitted its recommendations to Québec’s Minister of Finance for the 2016-2017 budget.
Read More
Submit the name of a candidate – an individual or a company - you feel deserves the award by April 30, 2017!
Read More
Their concentration, the nature of their involvement in research, and their economic power confirm that Québec’s CROs are a key element in the life sciences innovation chain.
Read More
BIOQuébec is celebrating the Québec government’s newly introduced balanced budget for 2017-2018, which contains elements to support the value creation of the biotechnology and life sciences industry.
Read More
MassBio’s 2017 Annual Meeting is this week! Will you be attending?
Read More
BIOQuébec and Pharmed are hosting this forum on contract research organizations (CROs) in 2017. Benefit from a $100 discount off the regular price of $395!
Read More
The Institut national d’excellence en santé et services sociaux (INESSS) recommended to use an affordable genetic screening test to avoid cases where patients experience complications following the Xeloda chemotherapy treatment, commonly known as 5-FU in its intravenously administered form.
Read More
Morphine and Fentanyl addiction, the cause of hundreds of overdose deaths in the country, could become a thing of the past.
Read More
Immuno-oncology has become increasingly prominent in the medical research industry.
Read More
Pierre Falardeau, VP of BIOQuébec’s Board of Directors, will be a lecturer at GRUM’s 3rd Scientific Symposium.
Read More
The need for easier access to funding for SMBs was an increasingly popular topic in both politics and finance recently.
Read More